Today’s article’s (1, 2, 3 ) are a break from the usual trials that are typically discussed and a bit more “benchside medicine” than bedside medicine. In fact, let’s look at this as an early request for one of the 12 trials of Christmas.
It should be noted that Klebsiellae, pseudomonads and acenetobacters were highly resistant to almost all of these drugs.
The MIC for phenothiazines are usually not reached with conventionally used doses, but these compounds do enhance the activity of various antibiotics to which various bacteria are susceptible (including vancomycin), and even decrease the MIC of resistant organisms.
So where am I going with all of this? For starters, lets look at some common causes of meningitis, in no specific order:
Strep pneumo (gram positive); group B strep (gram positive); staph aureus (gram positive); Listeria (gram positive); Neisseria meningitidis (gram neg diplococci); H flu (gram neg)
All things phenothiazines are thought to have activity against.
You’re likely to be giving patients with potential meningitis something for pain (I hope?), so why not go with compazine? Likewise, patients whom you may suspect bacteremia from a cellulitis, why not give compazine to, ummm, “counteract the nausea” associated with the opiates you gave for pain control?
I think this falls into the unlikely to harm, might help category, and is seemingly a ripe area for research. Is this practice changing? Nope, not at all. Food for thought, but until compazine is proven unsafe in an infectious process, I will continue my love affair with compazine for headaches, nausea, and vomiting (regardless of suspected etiology).